State Of Wisconsin Investment Board Arcutis Biotherapeutics, Inc. Transaction History
State Of Wisconsin Investment Board
- $36.9 Billion
- Q4 2024
A detailed history of State Of Wisconsin Investment Board transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 109,731 shares of ARQT stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,731
Previous 106,267
3.26%
Holding current value
$1.77 Million
Previous $988,000
54.66%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ARQT
# of Institutions
218Shares Held
129MCall Options Held
2.02MPut Options Held
202K-
Jennison Associates LLC12.3MShares$199 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.4MShares$183 Million6.61% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$176 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$141 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$139 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $968M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...